Total antioxidant levels are low during active TB and rise with anti-tuberculosis therapy

被引:50
|
作者
Wiid, I
Seaman, T
Hoal, EG
Benade, AJS
Van Helden, PD
机构
[1] Univ Stellenbosch, Fac Hlth Sci, Dept Med Biochem, MRC,Ctr Mol & Cellular Biol, ZA-7505 Tygerberg, South Africa
[2] MRC, Nutr Intervent Res Unit, ZA-7505 Tygerberg, South Africa
关键词
total antioxidant status; tuberculosis; chemotherapy; micronutrients;
D O I
10.1080/15216540410001671259
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In tuberculosis, oxidative stress is a result of tissue inflammation, poor dietary intake of micronutrients due to illness, free radical burst from activated macrophages, and anti-tuberculosis drugs. These free radicals may in turn contribute towards pulmonary inflammation if not neutralized by antioxidants. The total antioxidant status (TAS) of individuals is a function of dietary, enzymatic, and other systemic antioxidants and is therefore an indicator of the free radical load. Our aim was to evaluate the TAS of healthy and M. tuberculosis-infected persons from a high TB incidence community, as well as tuberculosis patients at various stages of antituberculosis drug treatment and to correlate results with plasma micronutrient levels. Blood plasma samples from TB infected patients and following antituberculosis drug treatment were assayed for TAS, vitamins A, E and Zinc. Statistical analysis of results was by one-way ANOVA and the Tukey multiple comparison post test. Active TB patients showed a significantly lower TAS (P<0.001) compared to the community controls. We also show that TAS values increase during therapy. Results correlated with micronutrients vitamin A and zinc but vitamin E remained unaffected. We suggest that total antioxidant status of TB patients should be considered for more effective disease control and that diets low in antioxidants may render individuals susceptible to tuberculosis.
引用
收藏
页码:101 / 106
页数:6
相关论文
共 50 条
  • [2] ANGIOTENSIN CONVERTING ENZYME (ACE) LEVELS IN TUBERCULOSIS PATIENTS DURING THE STANDARD ANTI-TUBERCULOSIS THERAPY
    MEHTA, J
    BERK, S
    BERK, S
    HUGHES, S
    SOUTHERN MEDICAL JOURNAL, 1987, 80 (09) : 6 - 6
  • [3] Metabolic Changes of Mycobacterium tuberculosis during the Anti-Tuberculosis Therapy
    Bespyatykh, Julia
    Shitikov, Egor
    Bespiatykh, Dmitry
    Guliaev, Andrei
    Klimina, Ksenia
    Veselovsky, Vladimir
    Arapidi, Georgij
    Dogonadze, Marine
    Zhuravlev, Viacheslav
    Ilina, Elena
    Govorun, Vadim
    PATHOGENS, 2020, 9 (02):
  • [4] PSYCHOSIS AND ANTI-TUBERCULOSIS THERAPY
    UPADHYAYA, MP
    CHATURVEDI, SK
    LANCET, 1989, 2 (8665): : 735 - 736
  • [5] PSYCHOSIS AND ANTI-TUBERCULOSIS THERAPY
    BALL, R
    ROSSER, R
    LANCET, 1989, 2 (8654): : 105 - 105
  • [6] Overview of anti-tuberculosis (TB) drugs and their resistance mechanisms
    Shi, Ruiru
    Itagaki, Nobunori
    Sugawara, Isamu
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2007, 7 (11) : 1177 - 1185
  • [7] Serial Testing of T-SPOT. TB Assays with Anti-Tuberculosis Therapy in Patients with Extrapulmonay Tuberculosis
    Park, Ki-Ho
    Cho, Oh-Hyun
    Ko, Gwang Beum
    Lee, Yumi
    Park, Hyun Jung
    Park, So-Youn
    Moon, Song Mi
    Chong, Young Pil
    Lee, Sang-Oh
    Choi, Sang-Ho
    Kim, Yang Soo
    Woo, Jun Hee
    Kim, Sung-Han
    INFECTION AND CHEMOTHERAPY, 2011, 43 (03): : 245 - 250
  • [8] Low serum concentrations of anti-tuberculosis drugs and determinants of their serum levels
    Um, S-W.
    Lee, S. W.
    Kwon, S. Y.
    Yoon, H. I.
    Park, K. U.
    Song, J.
    Lee, C-T.
    Lee, J-H.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2007, 11 (09) : 972 - 978
  • [9] AVOIDABLE ERRORS IN ANTI-TUBERCULOSIS THERAPY
    RADENBACH, KL
    BEITRAGE ZURKLINIK UND EREOSCHUNG DER TUBERKULOSE UND DER LUNGENKRANKHEITEN, 1969, 140 (1-4): : 128 - +
  • [10] MONITORING COMPLIANCE WITH ANTI-TUBERCULOSIS THERAPY
    PITCHENIK, AE
    NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (12): : 799 - 799